No Data
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 25% Dip In Price Shows Sentiment Is Matching Revenues
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19
Integra LifeSciences Is Maintained at Hold by Truist Securities
Express News | Integra Lifesciences Holdings Corp : Citigroup Cuts Target Price to $19 From $24
Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target Is $28
Money Mover OP : $Medtronic (MDT.US)$ $Intuitive Surgical (ISRG.US)$